Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). (Q33265701)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). |
scientific article |
Statements
1 reference
Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). (English)
1 reference
Rogério A Costa
1 reference
Ingrid U Scott
1 reference
Daniela Calucci
1 reference
Léssia P Cintra
1 reference
1 November 2006
1 reference
Identifiers
1 reference